Putative approaches to bypass the citrulline-specific autoimmune response in rheumatoid arthritis

Israel Medical Association Journal

Volumn 16, Issue 9, 2014, Pages 587-590

  Gertel, Smadar ^a   Amital, Howard ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti citrullinated protein antibodies (ACPA); Inflammation; Peptides; Rheumatoid arthritis (RA); Tolerance

Indexed keywords

AUTOANTIBODY; CITRULLINATED PROTEIN ANTIBODY; CITRULLINE; GLUCOSE REGULATED PROTEIN 78; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANTIPHOSPHOLIPID SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; ARTHRITIS, RHEUMATOID; BLOOD; IMMUNOLOGY; INFLAMMATION; MOLECULARLY TARGETED THERAPY; SYNOVIUM;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CITRULLINE; HUMANS; INFLAMMATION; MOLECULAR TARGETED THERAPY; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE;

EID: 84908096085     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005; 4 (3): 130-6. PubMed PMID: 15823498.
2. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmunity 2010; 34 (3): J258-65. PubMed PMID: 20042314.
3. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365 (23): 2205-19. PubMed PMID: 22150039.
4. Gyorgy B, Toth E, Tarcsa E, Falus A, Buzas EI. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 2006; 38 (10): 1662-77. PubMed PMID: 16730216.
5. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30 (11): 1205-13. PubMed PMID: 2446635.
6. Too CL, Yahya A, Murad S, et al. Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA). Arthritis Res Ther 2012; 14 (2): R89. PubMed PMID: 22537824. PubMed Central PMCID: 3446463.
7. Bongartz T, Cantaert T, Atkins SR, et al. Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology 2007; 46 (1): 70-5. PubMed PMID: 16782731.
8. Makrygiannakis D, af Klint E, Lundberg IE, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006; 65 (9): 1219-22. PubMed PMID: 16540548. PubMed Central PMCID: 1798285.
9. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003; 171 (2): 538-41. PubMed PMID: 12847215.
10. Snir O, Rieck M, Gebe JA, et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum 2011; 63 (10): 2873-83. PubMed PMID: 21567378. PubMed Central PMCID: 3174345.
11. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30 (5): 646-55. PubMed PMID: 19464987.
12. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Ann Rev Immunol 2010; 28: 445-89. PubMed PMID: 20192806. PubMed Central PMCID: 3502616.
13. Sakaguchi S. Regulatory T cells: key controllers of immunologic selftolerance. Cell 2000; 101 (5): 455-8. PubMed PMID: 10850488.
14. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nature Genet 2003; 34 (4): 395-402. PubMed PMID: 12833157.
15. Van Steendam K, De Ceuleneer M, Tilleman K, Elewaut D, De Keyser F, Deforce D. Quantification of IFNgamma- and IL17-producing cells after stimulation with citrullinated proteins in healthy subjects and RA patients. Rheum Int 2013; 33 (10): 2661-4. PubMed PMID: 22825303. PubMed Central PMCID: 3782635.
16. von Delwig A, Locke J, Robinson JH, Ng WF. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010; 62 (1): 143-9. PubMed PMID: 20039419.
17. Shin K, Hong S, Choi EH, et al. Role of citrullinated fibrinogen peptides in the activation of CD4 T cells from patients with rheumatoid arthritis. Immune Netw 2013; 13 (4): 116-22. PubMed PMID: 24009538. PubMed Central PMCID: 3759708.
18. Constantinescu CS, Hilliard B, Fujioka T, Bhopale MK, Calida D, Rostami AM. Pathogenesis of neuroimmunologic diseases. Experimental models. Immunol Res 1998; 17 (1-2): 217-27. PubMed PMID: 9479583.
19. Liu JQ, Bai XF, Shi FD, et al. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Int Immunol 1998; 10 (8): 1139-48. PubMed PMID: 9723700.
20. Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Treatment of autoimmune disease by oral tolerance to autoantigens. Clin Immunol Immunopathol 1996; 80 (3 Pt 2): S31-9. PubMed PMID: 8811061.
21. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991; 147 (7): 2155-63. PubMed PMID: 1717550.
22. Vander Cruyssen B, Cantaert T, Nogueira L, et al. Diagnostic value of antihuman citrullinated fibrinogen ELISA and comparison with four other anticitrullinated protein assays. Arthritis Res Ther 2006; 8 (4): R122. PubMed PMID: 16859515. PubMed Central PMCID: 1779401.
23. Vincent C, Nogueira L, Sebbag M, et al. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002; 46 (8): 2051-8. PubMed PMID: 12209508.
24. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62 (9): 2569-81PubMed PMID: 20872595.
25. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146 (11): 797-808. PubMed PMID: 17548411.
26. Steiner G. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin Rev Allergy Immunol 2007; 32 (1): 23-36. PubMed PMID: 17426358.
27. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233 (1): 34-54. PubMed PMID: 20192991.
28. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48 (10): 2741-9. PubMed PMID: 14558078.
29. Bukhari M, Thomson W, Naseem H, et al. The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 2007; 56 (9): 2929-35. PubMed PMID: 17763407. PubMed Central PMCID: 2435419.
30. Ronnelid J, Wick MC, Lampa J, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005; 64 (12):744-9. PubMed PMID: 15843452. PubMed Central PMCID: 1755292.
31. Clavel C, Nogueira L, Laurent L, et al. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008; 58 (3): 678-88. PubMed PMID: 18311806.
32. Trouw LA, Haisma EM, Levarht EW, et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009; 60 (7): 1923-31. PubMed PMID: 19565507.
33. Sokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum 2011; 63 (1): 53-62. PubMed PMID:20954191. PubMed Central PMCID: 3015008.
34. Lu MC, Lai NS, Yu HC, Huang HB, Hsieh SC, Yu CL. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/ macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum 2010; 62 (5): 1213-23. PubMed PMID: 20213805.
35. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013; 5 (178): 178-240. PubMed PMID: 23536012. PubMed Central PMCID: 3727661.
36. Bernard NJ. Rheumatoid arthritis: changes in ACPA Fc glycosylation patterns prior to RA onset. Nature Rev Rheumatol 2013; 9 (12): 697. PubMed PMID: 24166244.
37. Rombouts Y, Ewing E, van de Stadt LA, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 2013; doi:10.1136/ annrheumdis-2013-203565 PubMed PMID: 24106048.
38. Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116 (4): 961-73. PubMed PMID: 16585962. PubMed Central PMCID: 1421345.
39. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012; 122 (5): 1791-802. PubMed PMID: 22505457. PubMed Central PMCID: 3336988.
40. Blank M, Baraam L, Eisenstein M, et al. Beta2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3beta expression and reduces experimental-antiphospholipid-syndrome. J Autoimmunity 2011; 37 (1): 8-17. PubMed PMID: 21524885.